文献速递腹部CT

多期增强CT放射组学三分类鉴别肝癌亚型

Three-class radiomic differentiation of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma on multiphasic contrast-enhanced CT.
PubMed 文献 · Abdom Radiol (NY) · 2026-07-30

本研究基于278例病理确诊患者的四期增强CT,提取瘤内、瘤周、边界及背景肝放射组学特征,采用XGBoost嵌套交叉验证鉴别HCC、ICC与cHCC-CCA。背景肝特征单独表现接近全模型,嵌套交叉验证AUC达0.953±0.030,错分主要集中在ICC与cHCC-CCA交界。

要点

  • 背景肝与肿瘤-肝界面特征鉴别价值高于单纯瘤内特征,阅片时应关注肿瘤周围肝实质动脉期强化变化。
  • ICC与cHCC-CCA影像重叠最明显,报告中对两者鉴别诊断应保持审慎。
  • 该模型尚未经外部验证,不应单独用于术前病理替代诊断。

核心结论

  • 放射组学特征描述肿瘤-肝界面及瘤周微环境,在嵌套交叉验证中显示较高三分类鉴别效能,属假设生成性结果,需前瞻性外部验证。

研究设计与样本

  • 回顾性分析公开四期增强CT数据集,共278例病理确诊患者,其中94例HCC、99例ICC、85例cHCC-CCA。
  • 提取瘤内、瘤周、边界及背景肝放射组学特征共373个,经假发现率校正后行Kruskal-Wallis检验。
  • 以XGBoost分类器在嵌套交叉验证框架内比较四种特征选择策略,采用基于SHAP的top-K策略作为主要模型,并用置换检验验证模型显著性。

关键影像表现/征象

  • 动脉期肝实质参考衰减值在组间差异最为突出。
  • 错分主要发生在ICC与cHCC-CCA交界,错分病例衰减值向混淆类别偏移。
  • cHCC-CCA错分与正确分类病例之间未发现可区分变量。

诊断标准与关键数值

  • 373个特征中316个(84.7%)校正后组间差异显著。
  • 紧凑SHAP模型嵌套交叉验证AUC为0.953±0.030,折外宏AUC为0.948,置换检验p<0.001。
  • 背景肝特征单独消融分析接近全模型效能,并超过单纯瘤内特征。
  • 278例中48例(17.3%)被错分,集中于ICC与cHCC-CCA交界区域。

临床应用与阅片要点

  • 阅片时除观察肿瘤本身外,应重点评估肿瘤周围肝实质及肿瘤-肝界面的动脉期强化特征。
  • 对于表现为ICC与cHCC-CCA影像重叠的病例,建议报告中明确指出两者鉴别的不确定性。
  • 该放射组学模型尚不能作为术前无创诊断的独立依据,临床决策应结合病理或其他活检手段。

局限性

  • 属假设生成性研究,未经外部验证。
  • 使用的公开数据集样本量有限,仅278例。
  • cHCC-CCA错分与正确分类病例之间未发现可区分变量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Preoperative differentiation of hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined hepatocellular-cholangiocarcinoma (cHCC-CCA) remains clinically challenging due to overlapping imaging features. This study evaluated whether radiomic features from multiphasic contrast-enhanced CT can simultaneously differentiate these three primary liver cancer subtypes using a bias-aware machine learning framework.

METHODS: A publicly available four-phase contrast-enhanced CT (CECT) dataset of 278 pathologically confirmed patients (94 HCC, 99 ICC, 85 cHCC-CCA) was analyzed. Intratumoral, peritumoral, boundary, and background-liver radiomic features (n = 373) were compared across classes using the Kruskal-Wallis test with false discovery rate correction. An XGBoost classifier was trained within a nested cross-validation framework comparing four feature-selection strategies; the SHAP-based top-K strategy was retained as the primary model. Model significance was confirmed by permutation testing, and misclassified cases were characterized using key discriminative features.

RESULTS: Of 373 tested features, 316 (84.7%) showed significant intergroup differences after correction, led by arterial-phase liver-parenchyma reference attenuation ([Formula: see text]= 0.438). The compact SHAP-based model achieved a nested cross-validated AUC of 0.953 ± 0.030 (out-of-fold macro AUC 0.948; permutation p < 0.001). In a separate ablation analysis, background-liver features alone approached full-model performance, exceeding intratumoral features alone. Of 278 patients, 48 (17.3%) were misclassified, predominantly at the ICC-cHCC-CCA boundary; errors reflected attenuation values shifted toward the confounding class, except in cHCC-CCA, where no examined variable distinguished correctly from misclassified cases.

CONCLUSION: These findings are hypothesis-generating and require external validation; radiomic features describing the tumor-liver interface and peritumoral microenvironment showed high cross-validated discriminative performance and, pending prospective validation, may inform non-invasive assessment in cases of diagnostic uncertainty.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Arı. Three-class radiomic differentiation of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma on multiphasic contrast-enhanced CT. Abdom Radiol (NY). 2026. PMID: 42530595. doi:10.1007/s00261-026-05715-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。